Circulating Maternal Placental Growth Factor Responses to Low Molecular Weight Heparin in Pregnant Patients at Risk of Placental Dysfunction

Pregnancy and Childbirth

Urinary Placental Growth Factor for Prediction of Placental Adverse Outcomes in High-Risk Pregnancies

Obstet Gynecol.

Lecarpentier E, Gris JC, Cochery-Nouvellon E, Mercier E, Abbas H, Thadhani R, Karumanchi SA, Haddad B

doi: 10.1097/AOG.0000000000003547.

Pregnancy and Childbirth

Placental Growth Factor and the Risk of Adverse Neonatal and Maternal Outcomes

Obstet Gynecol.

Parchem JG, Brock CO, Chen HY, Kalluri R, Barton JR, Sibai BM, Preeclampsia Triage by Rapid Assay Trial (PETRA) Investigators.

doi: 10.1097/AOG.0000000000003694.

Pregnancy and Childbirth

Modifiable risk factors of maternal postpartum weight retention: an analysis of their combined impact and potential opportunities for prevention

Int J Obes (Lond).

Hollis JL, Crozier SR, Inskip HM, Cooper C, Godfrey KM, Harvey NC, Collins CE, Robinson SM

doi: 10.1038/ijo.2017.78.

Pregnancy and Childbirth

Placental function and fetal weight are associated with maternal hemodynamic indices in uncomplicated pregnancies at 35-37 weeks gestation

Am J Obstet Gynecol.

Garcia-Gonzalez C, Abdel-Azim S, Galeva S, Georgiopoulos G, Nicolaides KH, Charakida M

doi: 10.1016/j.ajog.2020.01.011.

Erectile and Sexual Functions and Dysfunctions

Erectile Dysfunction in Young Men-A Review of the Prevalence and Risk Factors

Sex Med Rev.

Nguyen HMT, Gabrielson AT, Hellstrom WJG

doi: 10.1016/j.sxmr.2017.05.004.

Erectile and Sexual Functions and Dysfunctions

Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?

J Sex Med.

Pozzi E, Capogrosso P, Boeri L, Belladelli F, Baudo A, Schifano N, Abbate C, Dehò F, Montorsi F, Salonia A

doi: 10.1016/j.jsxm.2020.03.012.

Pregnancy and Childbirth

Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves

J Am Coll Cardiol.

Steinberg ZL, Dominguez-Islas CP, Otto CM, Stout KK, Krieger EV

doi: 10.1016/j.jacc.2017.03.605.

Pregnancy and Childbirth

Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial

Clin Appl Thromb Hemost.

Shaaban OM, Abbas AM, Zahran KM, Fathalla MM, Anan MA, Salman SA

doi: 10.1177/

Pregnancy and Childbirth

Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study

Am J Obstet Gynecol.

Barton JR, Woelkers DA, Newman RB, Combs CA, How HY, Boggess KA, Martin JN Jr, Kupfer K, Sibai BM, PETRA (Preeclampsia Triage by Rapid Assay) Trial.

doi: 10.1016/j.ajog.2019.09.003.

Related content

Urinary Placental Growth Factor for Prediction of Placental Adverse Outcomes in High-Risk Pregnancies

Placental Growth Factor and the Risk of Adverse Neonatal and Maternal Outcomes

Modifiable risk factors of maternal postpartum weight retention: an analysis of their combined impact and potential opportunities for prevention

Placental function and fetal weight are associated with maternal hemodynamic indices in uncomplicated pregnancies at 35-37 weeks gestation

Erectile Dysfunction in Young Men-A Review of the Prevalence and Risk Factors

Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?

Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves

Low-Molecular-Weight Heparin for the Treatment of Unexplained Recurrent Miscarriage With Negative Antiphospholipid Antibodies: A Randomized Controlled Trial

Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study